Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Neoplasms | 131 | 2022 | 2530 | 5.450 |
Why?
|
Osteosarcoma | 69 | 2019 | 881 | 3.240 |
Why?
|
Bone Transplantation | 31 | 2021 | 907 | 1.900 |
Why?
|
Humerus | 8 | 2018 | 266 | 1.410 |
Why?
|
Soft Tissue Neoplasms | 26 | 2022 | 1363 | 1.330 |
Why?
|
Sarcoma | 26 | 2022 | 1897 | 1.280 |
Why?
|
Limb Salvage | 6 | 2016 | 433 | 1.110 |
Why?
|
Orthopedics | 14 | 2023 | 904 | 1.100 |
Why?
|
Orthopedic Procedures | 8 | 2015 | 1289 | 1.070 |
Why?
|
Femoral Neoplasms | 13 | 2016 | 77 | 1.030 |
Why?
|
Chondroma | 5 | 2013 | 58 | 1.030 |
Why?
|
Muscle Neoplasms | 7 | 2010 | 139 | 0.970 |
Why?
|
Osteochondroma | 4 | 2019 | 47 | 0.890 |
Why?
|
Tibia | 15 | 2016 | 1077 | 0.870 |
Why?
|
Fractures, Spontaneous | 10 | 2016 | 230 | 0.840 |
Why?
|
Fibula | 5 | 2016 | 269 | 0.770 |
Why?
|
Bone Cysts, Aneurysmal | 6 | 2007 | 73 | 0.710 |
Why?
|
Femur | 9 | 2021 | 1297 | 0.670 |
Why?
|
Osteoma, Osteoid | 9 | 2013 | 80 | 0.650 |
Why?
|
Curettage | 8 | 2008 | 73 | 0.540 |
Why?
|
Giant Cell Tumor of Bone | 8 | 2007 | 116 | 0.500 |
Why?
|
Burnout, Professional | 1 | 2023 | 694 | 0.500 |
Why?
|
Transplantation, Homologous | 30 | 2016 | 4777 | 0.480 |
Why?
|
Knee Joint | 6 | 2013 | 1680 | 0.480 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2013 | 40 | 0.460 |
Why?
|
Adolescent | 119 | 2022 | 85779 | 0.450 |
Why?
|
Chondrosarcoma | 10 | 2019 | 309 | 0.440 |
Why?
|
Epiphyses | 2 | 2013 | 189 | 0.430 |
Why?
|
Child | 108 | 2023 | 77709 | 0.430 |
Why?
|
Explosions | 1 | 2013 | 109 | 0.430 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 31 | 2019 | 11525 | 0.410 |
Why?
|
Mass Casualty Incidents | 1 | 2013 | 183 | 0.370 |
Why?
|
Fractures, Bone | 7 | 2015 | 1947 | 0.370 |
Why?
|
Bone Cysts | 3 | 2008 | 47 | 0.360 |
Why?
|
Diphosphonates | 2 | 2014 | 623 | 0.360 |
Why?
|
Blast Injuries | 1 | 2013 | 302 | 0.350 |
Why?
|
Osteoporotic Fractures | 1 | 2014 | 401 | 0.340 |
Why?
|
Osteolysis | 2 | 2014 | 270 | 0.340 |
Why?
|
Minority Groups | 2 | 2007 | 1221 | 0.340 |
Why?
|
Neoplasm Recurrence, Local | 30 | 2022 | 9240 | 0.330 |
Why?
|
Tomography, X-Ray Computed | 22 | 2017 | 20130 | 0.330 |
Why?
|
Radiography | 22 | 2023 | 7023 | 0.330 |
Why?
|
Doxorubicin | 25 | 2019 | 2234 | 0.320 |
Why?
|
Pelvic Neoplasms | 2 | 2004 | 254 | 0.320 |
Why?
|
Running | 1 | 2013 | 480 | 0.320 |
Why?
|
Biomedical Research | 7 | 2022 | 3309 | 0.320 |
Why?
|
Child, Preschool | 52 | 2016 | 41005 | 0.300 |
Why?
|
Ifosfamide | 12 | 2015 | 228 | 0.300 |
Why?
|
Humans | 229 | 2023 | 744366 | 0.290 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 772 | 0.290 |
Why?
|
Fracture Fixation | 3 | 2006 | 354 | 0.290 |
Why?
|
Combined Modality Therapy | 27 | 2017 | 8642 | 0.280 |
Why?
|
Neuroectodermal Tumors, Primitive | 5 | 2007 | 140 | 0.270 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4266 | 0.270 |
Why?
|
Musculoskeletal Diseases | 2 | 2018 | 581 | 0.270 |
Why?
|
Pain | 8 | 2020 | 4988 | 0.270 |
Why?
|
DNA, Neoplasm | 13 | 2017 | 1758 | 0.260 |
Why?
|
Periodicals as Topic | 4 | 2020 | 1431 | 0.260 |
Why?
|
Fractures, Ununited | 1 | 2006 | 165 | 0.260 |
Why?
|
Male | 144 | 2019 | 350115 | 0.260 |
Why?
|
Referral and Consultation | 1 | 2018 | 3531 | 0.250 |
Why?
|
Arthrodesis | 6 | 2002 | 189 | 0.250 |
Why?
|
Postoperative Complications | 17 | 2018 | 15297 | 0.250 |
Why?
|
Osteotomy | 8 | 2016 | 822 | 0.240 |
Why?
|
Disease-Free Survival | 22 | 2017 | 6896 | 0.240 |
Why?
|
Female | 148 | 2019 | 380193 | 0.230 |
Why?
|
Follow-Up Studies | 39 | 2022 | 39052 | 0.230 |
Why?
|
Cultural Diversity | 1 | 2007 | 359 | 0.220 |
Why?
|
Chemotherapy, Adjuvant | 15 | 2016 | 3480 | 0.220 |
Why?
|
Shoulder | 2 | 1998 | 299 | 0.220 |
Why?
|
Adult | 111 | 2019 | 214052 | 0.220 |
Why?
|
Editorial Policies | 3 | 2017 | 451 | 0.210 |
Why?
|
Diagnosis, Differential | 13 | 2014 | 12961 | 0.200 |
Why?
|
Biopsy, Needle | 6 | 2017 | 1641 | 0.200 |
Why?
|
Retrospective Studies | 42 | 2022 | 77460 | 0.200 |
Why?
|
Survival Rate | 23 | 2019 | 12788 | 0.190 |
Why?
|
Treatment Outcome | 39 | 2021 | 63107 | 0.190 |
Why?
|
Biopsy | 11 | 2018 | 6755 | 0.190 |
Why?
|
Boston | 8 | 2019 | 9312 | 0.190 |
Why?
|
Neoplasms | 5 | 2023 | 21696 | 0.180 |
Why?
|
Scapula | 2 | 2019 | 164 | 0.180 |
Why?
|
Chondroblastoma | 4 | 2005 | 50 | 0.170 |
Why?
|
Radiotherapy, Adjuvant | 8 | 2016 | 1771 | 0.170 |
Why?
|
Giant Cell Tumors | 4 | 2007 | 99 | 0.170 |
Why?
|
Conflict of Interest | 2 | 2014 | 544 | 0.170 |
Why?
|
Dermatitis, Occupational | 1 | 1998 | 27 | 0.170 |
Why?
|
Neoplasm Metastasis | 19 | 2019 | 4851 | 0.160 |
Why?
|
Hand Dermatoses | 1 | 1998 | 61 | 0.160 |
Why?
|
Extremities | 3 | 2010 | 866 | 0.160 |
Why?
|
Lipoma | 2 | 2001 | 334 | 0.160 |
Why?
|
RNA, Neoplasm | 2 | 2017 | 769 | 0.160 |
Why?
|
Osteolysis, Essential | 1 | 1998 | 30 | 0.160 |
Why?
|
Neoadjuvant Therapy | 7 | 2022 | 2727 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 12 | 2013 | 35425 | 0.150 |
Why?
|
Dermatitis, Allergic Contact | 1 | 1998 | 104 | 0.150 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1998 | 2232 | 0.150 |
Why?
|
Ribonucleases | 1 | 1997 | 287 | 0.140 |
Why?
|
Cyclophosphamide | 12 | 2009 | 2242 | 0.140 |
Why?
|
Fibromatosis, Aggressive | 3 | 2007 | 118 | 0.140 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 299 | 0.140 |
Why?
|
Cisplatin | 9 | 2019 | 1662 | 0.140 |
Why?
|
Treatment Failure | 5 | 2009 | 2618 | 0.140 |
Why?
|
Etoposide | 6 | 2015 | 641 | 0.140 |
Why?
|
Hypercalcemia | 2 | 2014 | 409 | 0.140 |
Why?
|
Myositis Ossificans | 2 | 2014 | 79 | 0.140 |
Why?
|
Infant | 24 | 2016 | 35134 | 0.130 |
Why?
|
Dermatitis | 1 | 1997 | 199 | 0.130 |
Why?
|
Genomic Imprinting | 1 | 2017 | 328 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2017 | 182 | 0.130 |
Why?
|
Survival Analysis | 11 | 2017 | 10252 | 0.130 |
Why?
|
Cause of Death | 2 | 2007 | 3582 | 0.130 |
Why?
|
Middle Aged | 64 | 2019 | 213390 | 0.130 |
Why?
|
Dehumanization | 1 | 2014 | 3 | 0.130 |
Why?
|
Methotrexate | 10 | 2019 | 1728 | 0.130 |
Why?
|
Pelvic Bones | 3 | 2006 | 265 | 0.130 |
Why?
|
Research Design | 4 | 2020 | 5984 | 0.120 |
Why?
|
Fluorometry | 1 | 1994 | 106 | 0.120 |
Why?
|
Professional Role | 1 | 2017 | 306 | 0.120 |
Why?
|
Forearm | 2 | 1996 | 409 | 0.120 |
Why?
|
Osteitis Deformans | 1 | 2014 | 53 | 0.120 |
Why?
|
Arthroplasty | 2 | 2014 | 305 | 0.120 |
Why?
|
Ganglion Cysts | 1 | 2014 | 28 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 432 | 0.120 |
Why?
|
Hospital Volunteers | 1 | 2013 | 6 | 0.120 |
Why?
|
Reoperation | 8 | 2018 | 4201 | 0.120 |
Why?
|
Catheter Ablation | 6 | 2005 | 2758 | 0.120 |
Why?
|
Osteomalacia | 1 | 2013 | 53 | 0.120 |
Why?
|
Ploidies | 5 | 2002 | 281 | 0.110 |
Why?
|
Granuloma, Plasma Cell | 1 | 2014 | 84 | 0.110 |
Why?
|
Societies, Medical | 1 | 2005 | 3743 | 0.110 |
Why?
|
Neoplasm Staging | 14 | 2005 | 11031 | 0.110 |
Why?
|
Cardiotonic Agents | 1 | 2015 | 535 | 0.100 |
Why?
|
Thermodilution | 1 | 2012 | 52 | 0.100 |
Why?
|
Surgical Wound Infection | 5 | 2016 | 1540 | 0.100 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2012 | 37 | 0.100 |
Why?
|
Transforming Growth Factor beta | 5 | 2002 | 2007 | 0.100 |
Why?
|
Radionuclide Imaging | 3 | 2013 | 2031 | 0.100 |
Why?
|
Risk Assessment | 9 | 2017 | 23336 | 0.100 |
Why?
|
Paraneoplastic Syndromes | 1 | 2013 | 151 | 0.100 |
Why?
|
Football | 1 | 2017 | 460 | 0.100 |
Why?
|
Drug Resistance, Multiple | 4 | 2000 | 252 | 0.100 |
Why?
|
Bone and Bones | 8 | 2001 | 2576 | 0.100 |
Why?
|
Time Factors | 20 | 2015 | 40075 | 0.100 |
Why?
|
Proportional Hazards Models | 7 | 2017 | 12356 | 0.100 |
Why?
|
Thigh | 3 | 2017 | 247 | 0.100 |
Why?
|
Fibrous Dysplasia of Bone | 2 | 2008 | 54 | 0.100 |
Why?
|
Switzerland | 4 | 2008 | 256 | 0.100 |
Why?
|
Risk Factors | 14 | 2022 | 72296 | 0.100 |
Why?
|
HIV | 1 | 1998 | 1604 | 0.090 |
Why?
|
Aged | 45 | 2018 | 163288 | 0.090 |
Why?
|
Prognosis | 18 | 2019 | 29060 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6539 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2014 | 9955 | 0.090 |
Why?
|
Dactinomycin | 6 | 2009 | 318 | 0.090 |
Why?
|
Neoplasms, Second Primary | 3 | 2007 | 1062 | 0.090 |
Why?
|
Bone Plates | 5 | 2006 | 468 | 0.090 |
Why?
|
Ameloblastoma | 3 | 1997 | 41 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2001 | 2219 | 0.090 |
Why?
|
Whole Body Imaging | 1 | 2012 | 280 | 0.090 |
Why?
|
Sex Distribution | 2 | 2005 | 2297 | 0.090 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2010 | 164 | 0.090 |
Why?
|
Chromosome Aberrations | 3 | 2007 | 1813 | 0.090 |
Why?
|
Joints | 3 | 2007 | 327 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15078 | 0.090 |
Why?
|
Cardiac Output | 1 | 2012 | 854 | 0.090 |
Why?
|
Truth Disclosure | 1 | 2013 | 436 | 0.090 |
Why?
|
Arthralgia | 1 | 2013 | 456 | 0.080 |
Why?
|
Age Distribution | 2 | 2005 | 2902 | 0.080 |
Why?
|
Translocation, Genetic | 2 | 2005 | 1420 | 0.080 |
Why?
|
Hematoma | 1 | 2014 | 758 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2099 | 0.080 |
Why?
|
MicroRNAs | 2 | 2017 | 3751 | 0.080 |
Why?
|
Flow Cytometry | 10 | 2002 | 5974 | 0.080 |
Why?
|
Age Factors | 9 | 2017 | 18373 | 0.080 |
Why?
|
Osteoblastoma | 1 | 2008 | 24 | 0.080 |
Why?
|
Knee | 1 | 1990 | 274 | 0.080 |
Why?
|
Logistic Models | 3 | 2016 | 13409 | 0.080 |
Why?
|
Adamantinoma | 1 | 2008 | 9 | 0.080 |
Why?
|
Vincristine | 6 | 2009 | 1039 | 0.080 |
Why?
|
Occupational Exposure | 1 | 1998 | 1793 | 0.080 |
Why?
|
Fracture Healing | 2 | 2002 | 427 | 0.080 |
Why?
|
Bone Matrix | 1 | 2008 | 118 | 0.080 |
Why?
|
Surgical Flaps | 2 | 2016 | 1640 | 0.080 |
Why?
|
Tumor Cells, Cultured | 13 | 2000 | 6313 | 0.080 |
Why?
|
Oxidoreductases | 1 | 2010 | 424 | 0.080 |
Why?
|
Prospective Studies | 14 | 2023 | 53290 | 0.080 |
Why?
|
Recurrence | 5 | 2008 | 8340 | 0.080 |
Why?
|
Specialty Boards | 2 | 2008 | 227 | 0.080 |
Why?
|
Injections, Intralesional | 1 | 2008 | 276 | 0.080 |
Why?
|
Fibroma | 3 | 1990 | 212 | 0.080 |
Why?
|
Tissue Banks | 2 | 1992 | 184 | 0.080 |
Why?
|
Employee Performance Appraisal | 1 | 2008 | 87 | 0.080 |
Why?
|
Preservation, Biological | 1 | 1987 | 25 | 0.080 |
Why?
|
Granuloma, Giant Cell | 1 | 2007 | 33 | 0.080 |
Why?
|
Diagnostic Imaging | 4 | 2023 | 3508 | 0.070 |
Why?
|
Young Adult | 9 | 2023 | 56429 | 0.070 |
Why?
|
Prostheses and Implants | 4 | 2022 | 1387 | 0.070 |
Why?
|
Seroma | 1 | 2007 | 71 | 0.070 |
Why?
|
Multivariate Analysis | 4 | 2016 | 12244 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2018 | 3841 | 0.070 |
Why?
|
Internship and Residency | 2 | 2007 | 5791 | 0.070 |
Why?
|
Salmonella Infections | 1 | 1988 | 173 | 0.070 |
Why?
|
Joint Prosthesis | 2 | 2004 | 258 | 0.070 |
Why?
|
Femoral Fractures | 3 | 2002 | 376 | 0.070 |
Why?
|
Shoulder Joint | 2 | 1991 | 695 | 0.070 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2006 | 99 | 0.070 |
Why?
|
Brain Concussion | 1 | 2017 | 1320 | 0.070 |
Why?
|
Amifostine | 1 | 2006 | 41 | 0.070 |
Why?
|
Pliability | 1 | 2006 | 63 | 0.070 |
Why?
|
Triage | 1 | 2013 | 977 | 0.070 |
Why?
|
Health Status Disparities | 2 | 2018 | 1796 | 0.070 |
Why?
|
Necrosis | 5 | 2022 | 1643 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1504 | 0.070 |
Why?
|
Chi-Square Distribution | 3 | 2004 | 3508 | 0.070 |
Why?
|
Periosteum | 2 | 2016 | 138 | 0.070 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2005 | 41 | 0.070 |
Why?
|
Topotecan | 1 | 2006 | 137 | 0.070 |
Why?
|
Professional Practice | 1 | 2008 | 326 | 0.070 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2005 | 19 | 0.070 |
Why?
|
Life Tables | 3 | 1997 | 370 | 0.070 |
Why?
|
Prostaglandins E | 1 | 1985 | 172 | 0.070 |
Why?
|
Torsion Abnormality | 1 | 2006 | 93 | 0.070 |
Why?
|
Cartilage, Articular | 2 | 1990 | 1095 | 0.060 |
Why?
|
Cell Nucleus | 1 | 1994 | 2969 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2001 | 1851 | 0.060 |
Why?
|
Compressive Strength | 1 | 2006 | 169 | 0.060 |
Why?
|
Remission, Spontaneous | 2 | 2005 | 382 | 0.060 |
Why?
|
Foot Diseases | 2 | 2004 | 143 | 0.060 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 1821 | 0.060 |
Why?
|
Ulna | 1 | 2006 | 133 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2016 | 14723 | 0.060 |
Why?
|
Aged, 80 and over | 15 | 2016 | 57776 | 0.060 |
Why?
|
Language | 1 | 2014 | 1471 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3921 | 0.060 |
Why?
|
Incidence | 5 | 2019 | 20952 | 0.060 |
Why?
|
Radius | 4 | 1998 | 422 | 0.060 |
Why?
|
Cohort Studies | 8 | 2019 | 40559 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2001 | 7182 | 0.060 |
Why?
|
Fibrosarcoma | 2 | 2002 | 348 | 0.060 |
Why?
|
Receptors, Transforming Growth Factor beta | 3 | 1995 | 314 | 0.060 |
Why?
|
Radiography, Interventional | 3 | 2017 | 1095 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3229 | 0.060 |
Why?
|
Certification | 1 | 2008 | 423 | 0.060 |
Why?
|
Leg | 3 | 2004 | 1116 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2012 | 1581 | 0.060 |
Why?
|
Privacy | 1 | 2006 | 238 | 0.060 |
Why?
|
Osteomyelitis | 1 | 1988 | 402 | 0.060 |
Why?
|
Women's Health | 1 | 2013 | 2034 | 0.060 |
Why?
|
Dog Diseases | 2 | 1997 | 138 | 0.060 |
Why?
|
Patient Care Team | 2 | 2013 | 2531 | 0.060 |
Why?
|
Methods | 3 | 1991 | 1129 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 437 | 0.060 |
Why?
|
Image Enhancement | 2 | 2012 | 2921 | 0.060 |
Why?
|
Graft Survival | 6 | 2002 | 3737 | 0.060 |
Why?
|
Disability Evaluation | 2 | 2016 | 1828 | 0.060 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2000 | 604 | 0.060 |
Why?
|
Spinal Diseases | 1 | 1988 | 538 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2013 | 1378 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2004 | 380 | 0.060 |
Why?
|
Bone Cements | 2 | 2001 | 325 | 0.050 |
Why?
|
Range of Motion, Articular | 5 | 2018 | 1578 | 0.050 |
Why?
|
Chromosomes, Human, X | 1 | 2004 | 296 | 0.050 |
Why?
|
Malpractice | 1 | 2008 | 572 | 0.050 |
Why?
|
Hospitals, University | 1 | 2004 | 570 | 0.050 |
Why?
|
Culture | 1 | 2007 | 633 | 0.050 |
Why?
|
Apatites | 3 | 1973 | 19 | 0.050 |
Why?
|
Quality of Life | 4 | 2022 | 12802 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 1998 | 4255 | 0.050 |
Why?
|
Ribs | 2 | 2003 | 252 | 0.050 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3154 | 0.050 |
Why?
|
Registries | 4 | 2005 | 8091 | 0.050 |
Why?
|
Methylmethacrylates | 2 | 1994 | 72 | 0.050 |
Why?
|
Propionibacterium acnes | 5 | 1979 | 66 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2010 | 2307 | 0.050 |
Why?
|
Calcium Phosphates | 3 | 1973 | 171 | 0.050 |
Why?
|
Osteosarcoma, Juxtacortical | 1 | 2000 | 2 | 0.050 |
Why?
|
Endopeptidases | 1 | 2004 | 772 | 0.050 |
Why?
|
Mesna | 3 | 2005 | 66 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2569 | 0.050 |
Why?
|
Polymethyl Methacrylate | 1 | 2001 | 145 | 0.050 |
Why?
|
Acridine Orange | 1 | 2000 | 26 | 0.050 |
Why?
|
Physicians, Women | 1 | 2007 | 486 | 0.050 |
Why?
|
Hand | 1 | 2006 | 884 | 0.050 |
Why?
|
Bone Resorption | 2 | 2000 | 723 | 0.050 |
Why?
|
Genes, p53 | 2 | 1994 | 755 | 0.050 |
Why?
|
Stress, Mechanical | 1 | 2006 | 1686 | 0.050 |
Why?
|
Cytogenetics | 1 | 2001 | 203 | 0.050 |
Why?
|
Research Support as Topic | 1 | 2005 | 705 | 0.050 |
Why?
|
Oncogene Proteins | 1 | 2004 | 749 | 0.050 |
Why?
|
Prevalence | 2 | 2016 | 15221 | 0.050 |
Why?
|
Probability | 2 | 2004 | 2506 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2008 | 2765 | 0.050 |
Why?
|
Peptides | 1 | 2012 | 4410 | 0.050 |
Why?
|
Disease Progression | 7 | 2016 | 13286 | 0.040 |
Why?
|
Ankle Joint | 2 | 2016 | 411 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11366 | 0.040 |
Why?
|
Cadherins | 1 | 2004 | 907 | 0.040 |
Why?
|
Arthroplasty, Replacement | 1 | 2004 | 339 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2850 | 0.040 |
Why?
|
Polyploidy | 1 | 2000 | 114 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2004 | 477 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1677 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2005 | 1179 | 0.040 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 1992 | 241 | 0.040 |
Why?
|
Drug Administration Schedule | 5 | 2007 | 4933 | 0.040 |
Why?
|
Recovery of Function | 3 | 2018 | 2926 | 0.040 |
Why?
|
Osteoblasts | 2 | 2008 | 1166 | 0.040 |
Why?
|
Ilium | 1 | 2000 | 154 | 0.040 |
Why?
|
Vocational Education | 1 | 1998 | 6 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1856 | 0.040 |
Why?
|
Point Mutation | 2 | 1996 | 1624 | 0.040 |
Why?
|
Food-Processing Industry | 1 | 1998 | 15 | 0.040 |
Why?
|
Staphylococcal Infections | 1 | 1988 | 1400 | 0.040 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 1998 | 34 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3326 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2010 | 2971 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2005 | 1680 | 0.040 |
Why?
|
Radiotherapy Dosage | 4 | 2009 | 2879 | 0.040 |
Why?
|
Regression Analysis | 2 | 2001 | 6459 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2004 | 547 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2017 | 1405 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3616 | 0.040 |
Why?
|
Hyperparathyroidism | 1 | 2000 | 339 | 0.040 |
Why?
|
Algorithms | 5 | 2012 | 13882 | 0.040 |
Why?
|
Chordoma | 1 | 2002 | 359 | 0.040 |
Why?
|
Forecasting | 2 | 2006 | 2951 | 0.040 |
Why?
|
Parathyroid Neoplasms | 1 | 2000 | 245 | 0.040 |
Why?
|
Prosthesis Failure | 1 | 2004 | 1206 | 0.040 |
Why?
|
Tissue Donors | 2 | 1987 | 2241 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2010 | 5172 | 0.040 |
Why?
|
Carboplatin | 1 | 2001 | 801 | 0.040 |
Why?
|
Activities of Daily Living | 3 | 2004 | 2419 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1643 | 0.040 |
Why?
|
Eosinophil Granule Proteins | 1 | 1997 | 30 | 0.040 |
Why?
|
Infant, Newborn | 6 | 2015 | 25628 | 0.040 |
Why?
|
Immunotherapy | 5 | 2012 | 4446 | 0.040 |
Why?
|
Homosexuality | 2 | 1999 | 262 | 0.040 |
Why?
|
Employment | 1 | 2004 | 1132 | 0.040 |
Why?
|
Abdominal Neoplasms | 1 | 1999 | 292 | 0.040 |
Why?
|
United States | 6 | 2022 | 69872 | 0.040 |
Why?
|
Diseases in Twins | 1 | 1979 | 449 | 0.040 |
Why?
|
Analgesics | 1 | 2004 | 1040 | 0.040 |
Why?
|
Tumor Burden | 2 | 2016 | 1915 | 0.040 |
Why?
|
Utah | 1 | 2017 | 126 | 0.040 |
Why?
|
Hair Diseases | 1 | 1997 | 74 | 0.040 |
Why?
|
Teratoma | 1 | 2000 | 395 | 0.040 |
Why?
|
Karyotyping | 2 | 1996 | 1243 | 0.040 |
Why?
|
Menisci, Tibial | 1 | 1979 | 269 | 0.040 |
Why?
|
Hemangioma | 1 | 2002 | 738 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2002 | 838 | 0.040 |
Why?
|
Suction | 1 | 1998 | 267 | 0.040 |
Why?
|
Hyaluronoglucosaminidase | 1 | 1996 | 133 | 0.040 |
Why?
|
Cooking | 1 | 1998 | 313 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5181 | 0.030 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1997 | 349 | 0.030 |
Why?
|
Keratins | 1 | 1997 | 515 | 0.030 |
Why?
|
Arthroscopy | 2 | 2001 | 926 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1997 | 573 | 0.030 |
Why?
|
Postoperative Period | 2 | 2018 | 1842 | 0.030 |
Why?
|
Simian virus 40 | 1 | 1996 | 297 | 0.030 |
Why?
|
Antigen-Antibody Complex | 1 | 1997 | 517 | 0.030 |
Why?
|
Oncogenes | 2 | 2005 | 1265 | 0.030 |
Why?
|
Odds Ratio | 1 | 2008 | 9849 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9584 | 0.030 |
Why?
|
Mammary Neoplasms, Experimental | 4 | 1979 | 520 | 0.030 |
Why?
|
Databases as Topic | 3 | 2006 | 475 | 0.030 |
Why?
|
Thumb | 2 | 2007 | 227 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 1996 | 169 | 0.030 |
Why?
|
Glutathione | 1 | 1998 | 590 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16690 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2002 | 1275 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2017 | 8432 | 0.030 |
Why?
|
Evaluation Studies as Topic | 4 | 1993 | 1681 | 0.030 |
Why?
|
Ventricular Dysfunction | 1 | 2015 | 143 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2005 | 15535 | 0.030 |
Why?
|
Cell Cycle | 3 | 2002 | 2967 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 1986 | 3759 | 0.030 |
Why?
|
Radiotherapy | 3 | 2005 | 1533 | 0.030 |
Why?
|
Hip Joint | 1 | 2021 | 1002 | 0.030 |
Why?
|
Bleomycin | 2 | 2003 | 512 | 0.030 |
Why?
|
Hair | 1 | 1997 | 481 | 0.030 |
Why?
|
Suramin | 1 | 1994 | 34 | 0.030 |
Why?
|
Metabolism, Inborn Errors | 1 | 1996 | 288 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1158 | 0.030 |
Why?
|
Preoperative Care | 3 | 2009 | 2251 | 0.030 |
Why?
|
Phencyclidine | 1 | 1994 | 61 | 0.030 |
Why?
|
Animals | 27 | 2012 | 168768 | 0.030 |
Why?
|
Leg Bones | 2 | 2007 | 19 | 0.030 |
Why?
|
Dupuytren Contracture | 1 | 1995 | 62 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7658 | 0.030 |
Why?
|
Asia | 1 | 2015 | 609 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2009 | 6366 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 2 | 1999 | 525 | 0.030 |
Why?
|
Body Weight | 1 | 2004 | 4671 | 0.030 |
Why?
|
Histiocytoma, Benign Fibrous | 2 | 2002 | 109 | 0.030 |
Why?
|
Carbonates | 1 | 1973 | 21 | 0.030 |
Why?
|
Electrophoresis | 1 | 1993 | 240 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3611 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 1997 | 1537 | 0.030 |
Why?
|
Blood Proteins | 1 | 1997 | 1124 | 0.030 |
Why?
|
Genes, Retinoblastoma | 1 | 1992 | 136 | 0.030 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1994 | 249 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4687 | 0.030 |
Why?
|
Cultural Characteristics | 1 | 2013 | 262 | 0.030 |
Why?
|
HLA-A2 Antigen | 1 | 2012 | 213 | 0.030 |
Why?
|
Propidium | 1 | 1991 | 41 | 0.030 |
Why?
|
Australia | 1 | 2015 | 1167 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1994 | 730 | 0.030 |
Why?
|
Vinblastine | 2 | 2007 | 502 | 0.030 |
Why?
|
North America | 1 | 2015 | 1249 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 1997 | 1463 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 1996 | 1097 | 0.020 |
Why?
|
Culture Media | 3 | 1994 | 909 | 0.020 |
Why?
|
Transplantation, Heterotopic | 1 | 1991 | 175 | 0.020 |
Why?
|
Dacarbazine | 2 | 2005 | 566 | 0.020 |
Why?
|
Li-Fraumeni Syndrome | 1 | 1992 | 114 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1993 | 2949 | 0.020 |
Why?
|
Focus Groups | 1 | 2016 | 1321 | 0.020 |
Why?
|
Health Status | 1 | 2004 | 4034 | 0.020 |
Why?
|
Bone Screws | 2 | 2001 | 520 | 0.020 |
Why?
|
Mice | 15 | 2012 | 81201 | 0.020 |
Why?
|
Fractures, Closed | 1 | 1991 | 88 | 0.020 |
Why?
|
Interferon-alpha | 1 | 2015 | 895 | 0.020 |
Why?
|
Tibial Fractures | 2 | 1991 | 269 | 0.020 |
Why?
|
Cell Division | 5 | 2000 | 4569 | 0.020 |
Why?
|
Etidronic Acid | 1 | 1990 | 64 | 0.020 |
Why?
|
Sarcoma, Kaposi | 1 | 1994 | 370 | 0.020 |
Why?
|
Dermatitis, Atopic | 1 | 1997 | 654 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2005 | 648 | 0.020 |
Why?
|
Fractures, Open | 1 | 1991 | 101 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2000 | 547 | 0.020 |
Why?
|
Exostoses | 1 | 1990 | 30 | 0.020 |
Why?
|
Actins | 1 | 1998 | 2121 | 0.020 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.020 |
Why?
|
Mastectomy | 1 | 1978 | 1793 | 0.020 |
Why?
|
Crystallization | 2 | 1971 | 525 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6621 | 0.020 |
Why?
|
Expert Systems | 1 | 2010 | 81 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1975 | 1180 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2008 | 2649 | 0.020 |
Why?
|
Checklist | 1 | 2017 | 833 | 0.020 |
Why?
|
Antineoplastic Agents | 6 | 2001 | 13693 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2227 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1182 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 399 | 0.020 |
Why?
|
Psoriasis | 1 | 1997 | 902 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2001 | 1458 | 0.020 |
Why?
|
Rats, Inbred Lew | 2 | 2002 | 1162 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3528 | 0.020 |
Why?
|
Adenoma | 1 | 2000 | 2174 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 1975 | 894 | 0.020 |
Why?
|
Gynecology | 1 | 1975 | 513 | 0.020 |
Why?
|
Molecular Sequence Data | 7 | 1997 | 18111 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2010 | 211 | 0.020 |
Why?
|
Drug Utilization | 1 | 1975 | 1183 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9445 | 0.020 |
Why?
|
Length of Stay | 2 | 1999 | 6311 | 0.020 |
Why?
|
Pediatrics | 1 | 2004 | 3475 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1997 | 1888 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3338 | 0.020 |
Why?
|
HIV Infections | 2 | 2008 | 16715 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7721 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 1998 | 6489 | 0.020 |
Why?
|
Knee Prosthesis | 1 | 1991 | 425 | 0.020 |
Why?
|
Governing Board | 1 | 2008 | 53 | 0.020 |
Why?
|
Ankle | 2 | 2004 | 327 | 0.020 |
Why?
|
Internal Medicine | 1 | 1975 | 1009 | 0.020 |
Why?
|
Polymerase Chain Reaction | 5 | 1997 | 6171 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2480 | 0.020 |
Why?
|
Arm Bones | 1 | 2007 | 4 | 0.020 |
Why?
|
Elbow Joint | 2 | 1991 | 357 | 0.020 |
Why?
|
Fluoresceins | 1 | 1988 | 235 | 0.020 |
Why?
|
Braces | 1 | 1988 | 136 | 0.020 |
Why?
|
Sacrococcygeal Region | 1 | 2007 | 52 | 0.020 |
Why?
|
Physician Impairment | 1 | 2008 | 73 | 0.020 |
Why?
|
HIV-1 | 2 | 2008 | 6939 | 0.020 |
Why?
|
Median Nerve | 1 | 1987 | 129 | 0.020 |
Why?
|
Breast Neoplasms | 4 | 1994 | 20824 | 0.020 |
Why?
|
Comorbidity | 1 | 2001 | 10388 | 0.020 |
Why?
|
Base Sequence | 5 | 1997 | 12797 | 0.020 |
Why?
|
ras Proteins | 1 | 2012 | 1060 | 0.020 |
Why?
|
Palate | 1 | 2007 | 123 | 0.020 |
Why?
|
Trisomy | 1 | 2008 | 266 | 0.020 |
Why?
|
Infusions, Intravenous | 2 | 2002 | 2274 | 0.020 |
Why?
|
Metacarpal Bones | 1 | 2007 | 73 | 0.020 |
Why?
|
DNA | 5 | 1995 | 7294 | 0.020 |
Why?
|
Growth Substances | 1 | 1989 | 784 | 0.020 |
Why?
|
Bone Diseases | 1 | 1990 | 416 | 0.020 |
Why?
|
Jejunal Neoplasms | 1 | 1986 | 18 | 0.020 |
Why?
|
Cross Reactions | 2 | 2000 | 841 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2007 | 667 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 1987 | 160 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2000 | 2736 | 0.020 |
Why?
|
Joint Diseases | 1 | 1990 | 479 | 0.020 |
Why?
|
Prostaglandins E, Synthetic | 1 | 1985 | 14 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 1994 | 1788 | 0.020 |
Why?
|
Swine | 2 | 2012 | 5918 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 1997 | 4561 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2000 | 11486 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1837 | 0.020 |
Why?
|
Ethics Committees, Research | 1 | 2006 | 194 | 0.020 |
Why?
|
Spectral Karyotyping | 1 | 2004 | 12 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10943 | 0.020 |
Why?
|
Mass Screening | 1 | 2001 | 5253 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1985 | 919 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2007 | 1420 | 0.020 |
Why?
|
Foot Bones | 1 | 2004 | 24 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2008 | 2943 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 3554 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2000 | 692 | 0.020 |
Why?
|
Hallux | 1 | 2004 | 40 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2012 | 2012 | 0.010 |
Why?
|
Osteoclasts | 1 | 2008 | 729 | 0.010 |
Why?
|
Protective Agents | 1 | 2005 | 156 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1783 | 0.010 |
Why?
|
Mutation | 3 | 2004 | 29786 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1912 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 2005 | 5867 | 0.010 |
Why?
|
Osteogenesis | 1 | 1990 | 1299 | 0.010 |
Why?
|
Tendons | 1 | 1987 | 548 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1975 | 1877 | 0.010 |
Why?
|
Cartilage | 1 | 1987 | 818 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 640 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4285 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 624 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2715 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2008 | 970 | 0.010 |
Why?
|
Mice, Inbred C3H | 5 | 1988 | 964 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8319 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3922 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2000 | 2027 | 0.010 |
Why?
|
Pelvis | 1 | 2007 | 730 | 0.010 |
Why?
|
Exons | 3 | 1994 | 2439 | 0.010 |
Why?
|
Bony Callus | 1 | 2002 | 36 | 0.010 |
Why?
|
Dinoprostone | 1 | 1985 | 601 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1999 | 4262 | 0.010 |
Why?
|
Sex Factors | 2 | 2013 | 10400 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2007 | 973 | 0.010 |
Why?
|
Collagen Type I | 1 | 2005 | 592 | 0.010 |
Why?
|
Proteoglycans | 1 | 2005 | 837 | 0.010 |
Why?
|
Hip Prosthesis | 1 | 1988 | 917 | 0.010 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2004 | 449 | 0.010 |
Why?
|
Joint Loose Bodies | 1 | 2001 | 19 | 0.010 |
Why?
|
Leucovorin | 1 | 2003 | 628 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2004 | 868 | 0.010 |
Why?
|
Diploidy | 1 | 2001 | 138 | 0.010 |
Why?
|
S Phase | 1 | 2002 | 423 | 0.010 |
Why?
|
Radiation | 1 | 2000 | 49 | 0.010 |
Why?
|
Saponins | 1 | 2000 | 50 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1992 | 2542 | 0.010 |
Why?
|
Hot Temperature | 2 | 2001 | 1356 | 0.010 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2002 | 350 | 0.010 |
Why?
|
Informed Consent | 1 | 2006 | 995 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2000 | 349 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3519 | 0.010 |
Why?
|
Mitotic Index | 1 | 2000 | 172 | 0.010 |
Why?
|
Internal Fixators | 1 | 2001 | 188 | 0.010 |
Why?
|
Verapamil | 1 | 2000 | 244 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9735 | 0.010 |
Why?
|
Bones of Upper Extremity | 1 | 1999 | 6 | 0.010 |
Why?
|
Wound Healing | 2 | 2001 | 2785 | 0.010 |
Why?
|
Dogs | 2 | 1997 | 3912 | 0.010 |
Why?
|
Orthopedic Fixation Devices | 1 | 1999 | 75 | 0.010 |
Why?
|
Neurofibromatosis 1 | 1 | 2004 | 570 | 0.010 |
Why?
|
Signal Transduction | 2 | 2012 | 23404 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12952 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 1987 | 896 | 0.010 |
Why?
|
Rats | 4 | 2002 | 24252 | 0.010 |
Why?
|
Cytochalasin B | 1 | 1998 | 74 | 0.010 |
Why?
|
Gene Products, env | 1 | 1999 | 263 | 0.010 |
Why?
|
Aneuploidy | 1 | 2002 | 530 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6194 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5077 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 590 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1998 | 5692 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1986 | 1131 | 0.010 |
Why?
|
History, 18th Century | 1 | 1978 | 213 | 0.010 |
Why?
|
Health Surveys | 1 | 2008 | 4036 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 2000 | 235 | 0.010 |
Why?
|
Lung Neoplasms | 4 | 2008 | 13104 | 0.010 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2000 | 156 | 0.010 |
Why?
|
Tuberculosis | 1 | 1971 | 1912 | 0.010 |
Why?
|
Cell Movement | 1 | 2010 | 5218 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9688 | 0.010 |
Why?
|
Molecular Weight | 1 | 2000 | 2255 | 0.010 |
Why?
|
Transplants | 1 | 2000 | 209 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 1979 | 458 | 0.010 |
Why?
|
Cells, Cultured | 3 | 1995 | 19233 | 0.010 |
Why?
|
Heterosexuality | 1 | 1999 | 276 | 0.010 |
Why?
|
Amino Acid Sequence | 3 | 1997 | 13814 | 0.010 |
Why?
|
Liver Regeneration | 1 | 1979 | 210 | 0.010 |
Why?
|
Catalase | 1 | 1998 | 221 | 0.010 |
Why?
|
Marketing of Health Services | 1 | 1998 | 153 | 0.010 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1997 | 136 | 0.010 |
Why?
|
Nausea | 1 | 2000 | 674 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4751 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2000 | 867 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2000 | 692 | 0.010 |
Why?
|
Vomiting | 1 | 2000 | 637 | 0.010 |
Why?
|
Genome, Human | 1 | 2010 | 4420 | 0.010 |
Why?
|
Chronic Disease | 2 | 1990 | 9145 | 0.010 |
Why?
|
Clone Cells | 1 | 2000 | 1692 | 0.010 |
Why?
|
Bacterial Vaccines | 1 | 1979 | 403 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2000 | 537 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1978 | 307 | 0.010 |
Why?
|
Lymphoma | 1 | 1985 | 1877 | 0.010 |
Why?
|
Neutropenia | 1 | 2002 | 895 | 0.010 |
Why?
|
Histiocytes | 1 | 1996 | 103 | 0.010 |
Why?
|
History, 19th Century | 1 | 1978 | 720 | 0.010 |
Why?
|
Sarcoma, Experimental | 1 | 1996 | 128 | 0.010 |
Why?
|
Wrist Joint | 1 | 1998 | 256 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2005 | 1903 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4222 | 0.010 |
Why?
|
Cytoplasm | 1 | 2000 | 1536 | 0.010 |
Why?
|
Colorimetry | 1 | 1996 | 147 | 0.010 |
Why?
|
Germany | 1 | 1997 | 862 | 0.010 |
Why?
|
Mink | 1 | 1995 | 44 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1996 | 803 | 0.010 |
Why?
|
Models, Animal | 1 | 2002 | 2173 | 0.010 |
Why?
|
Mental Disorders | 1 | 1975 | 6598 | 0.010 |
Why?
|
Rabbits | 2 | 1973 | 4894 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25039 | 0.010 |
Why?
|
Critical Care | 1 | 2007 | 2647 | 0.010 |
Why?
|
Barbiturates | 1 | 1975 | 114 | 0.010 |
Why?
|
Mitosis | 1 | 2000 | 1208 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1994 | 326 | 0.010 |
Why?
|
Prosthesis Implantation | 1 | 1999 | 642 | 0.010 |
Why?
|
Isomerism | 1 | 1994 | 201 | 0.010 |
Why?
|
North Carolina | 1 | 1975 | 315 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1997 | 1799 | 0.010 |
Why?
|
RNA | 1 | 2004 | 2749 | 0.010 |
Why?
|
Patient Selection | 1 | 2006 | 4216 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6364 | 0.010 |
Why?
|
Survival | 1 | 1994 | 163 | 0.010 |
Why?
|
Growth Plate | 1 | 1996 | 274 | 0.010 |
Why?
|
Neoplasm Transplantation | 2 | 1988 | 2086 | 0.010 |
Why?
|
Hospitals | 1 | 2008 | 3954 | 0.010 |
Why?
|
Femur Neck | 1 | 1995 | 309 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19905 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9724 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2002 | 1178 | 0.010 |
Why?
|
Contrast Media | 1 | 2007 | 5300 | 0.010 |
Why?
|
Arm | 1 | 1996 | 589 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2003 | 2038 | 0.010 |
Why?
|
Fingers | 1 | 1996 | 513 | 0.010 |
Why?
|
Cadaver | 2 | 1988 | 1337 | 0.010 |
Why?
|
Phantom Limb | 1 | 1994 | 91 | 0.010 |
Why?
|
Electrodes | 1 | 1995 | 619 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2003 | 2638 | 0.010 |
Why?
|
BCG Vaccine | 2 | 1978 | 369 | 0.010 |
Why?
|
Hyaluronic Acid | 1 | 1996 | 491 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1996 | 2646 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 1 | 1993 | 111 | 0.010 |
Why?
|
Prosthesis Design | 1 | 1999 | 2110 | 0.010 |
Why?
|
Genome, Viral | 1 | 1996 | 667 | 0.010 |
Why?
|
Phenotype | 2 | 2000 | 16367 | 0.010 |
Why?
|
Anti-Anxiety Agents | 1 | 1975 | 390 | 0.010 |
Why?
|
Random Allocation | 1 | 1997 | 2428 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 1973 | 420 | 0.010 |
Why?
|
Social Adjustment | 1 | 1994 | 631 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4554 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 6476 | 0.010 |
Why?
|
Tissue Preservation | 1 | 1992 | 182 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1999 | 760 | 0.010 |
Why?
|
Orthotic Devices | 1 | 1993 | 128 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1995 | 709 | 0.010 |
Why?
|
Germany, West | 1 | 1971 | 13 | 0.010 |
Why?
|
Growth Disorders | 1 | 1996 | 645 | 0.010 |
Why?
|
Interview, Psychological | 1 | 1994 | 812 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.010 |
Why?
|
Ethyl Ethers | 1 | 1970 | 20 | 0.010 |
Why?
|
Pregnancy | 3 | 1996 | 29144 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1978 | 2924 | 0.010 |
Why?
|
Ambulatory Surgical Procedures | 1 | 1995 | 455 | 0.010 |
Why?
|
Acetone | 1 | 1970 | 43 | 0.010 |
Why?
|
History, 20th Century | 1 | 1978 | 2740 | 0.010 |
Why?
|
Musculoskeletal System | 1 | 1993 | 175 | 0.010 |
Why?
|
Osteoma | 1 | 1990 | 12 | 0.010 |
Why?
|
Locomotion | 1 | 1993 | 378 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1990 | 878 | 0.010 |
Why?
|
Faculty, Medical | 1 | 1998 | 1181 | 0.010 |
Why?
|
Cattle | 1 | 1996 | 3922 | 0.010 |
Why?
|
Remission Induction | 1 | 1995 | 2385 | 0.010 |
Why?
|
Drug Resistance | 1 | 1996 | 1608 | 0.010 |
Why?
|
Pedigree | 1 | 1997 | 4642 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1994 | 1401 | 0.010 |
Why?
|
Fertility | 1 | 1994 | 781 | 0.010 |
Why?
|
Minerals | 1 | 1971 | 275 | 0.010 |
Why?
|
Solvents | 1 | 1970 | 302 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 2186 | 0.010 |
Why?
|
Infrared Rays | 1 | 1970 | 249 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2000 | 8300 | 0.010 |
Why?
|
Fetus | 1 | 1996 | 1880 | 0.000 |
Why?
|
DNA Repair | 1 | 1998 | 2046 | 0.000 |
Why?
|
Trypan Blue | 1 | 1988 | 21 | 0.000 |
Why?
|
DNA Primers | 1 | 1993 | 2891 | 0.000 |
Why?
|
Spectrum Analysis | 1 | 1970 | 454 | 0.000 |
Why?
|
Neuralgia | 1 | 1994 | 570 | 0.000 |
Why?
|
Thymidine | 1 | 1988 | 310 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9647 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1987 | 378 | 0.000 |
Why?
|
Radiopharmaceuticals | 1 | 1997 | 2645 | 0.000 |
Why?
|
Freezing | 1 | 1988 | 303 | 0.000 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1990 | 1723 | 0.000 |
Why?
|
Rupture, Spontaneous | 1 | 1987 | 354 | 0.000 |
Why?
|
Disease Models, Animal | 2 | 2000 | 18034 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1997 | 4805 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1998 | 3589 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1990 | 2505 | 0.000 |
Why?
|
Antibodies | 1 | 1994 | 2460 | 0.000 |
Why?
|
Brachial Artery | 1 | 1987 | 369 | 0.000 |
Why?
|
Tomography | 2 | 1982 | 390 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1986 | 219 | 0.000 |
Why?
|
Computers | 1 | 1988 | 612 | 0.000 |
Why?
|
Drug Prescriptions | 1 | 1975 | 1637 | 0.000 |
Why?
|
Ulna Fractures | 1 | 1986 | 125 | 0.000 |
Why?
|
Transcription Factors | 1 | 2005 | 12207 | 0.000 |
Why?
|
Rhabdomyosarcoma | 1 | 1988 | 382 | 0.000 |
Why?
|
Morbidity | 1 | 1971 | 1768 | 0.000 |
Why?
|
Organ Preservation | 1 | 1988 | 331 | 0.000 |
Why?
|
Depression | 2 | 1994 | 7759 | 0.000 |
Why?
|
Genetic Markers | 1 | 1991 | 2634 | 0.000 |
Why?
|
Inflammation | 1 | 2004 | 10637 | 0.000 |
Why?
|
Histocytochemistry | 1 | 1986 | 719 | 0.000 |
Why?
|
Fracture Fixation, Internal | 1 | 1991 | 917 | 0.000 |
Why?
|
Intraoperative Care | 1 | 1988 | 767 | 0.000 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1971 | 810 | 0.000 |
Why?
|
Fibroblasts | 1 | 1995 | 4162 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1993 | 4185 | 0.000 |
Why?
|
Communicable Disease Control | 1 | 1971 | 856 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1970 | 2373 | 0.000 |
Why?
|
Liver | 1 | 1979 | 7475 | 0.000 |
Why?
|
Antidepressive Agents | 1 | 1975 | 2838 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1978 | 7914 | 0.000 |
Why?
|
Transfection | 1 | 1990 | 5895 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1993 | 2575 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 1975 | 3057 | 0.000 |
Why?
|
Carcinoma | 1 | 1992 | 2375 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1996 | 13035 | 0.000 |
Why?
|
Genetic Testing | 1 | 1993 | 3444 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1994 | 4245 | 0.000 |
Why?
|
Hepatomegaly | 1 | 1979 | 85 | 0.000 |
Why?
|
Brucella Vaccine | 1 | 1978 | 3 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1996 | 9274 | 0.000 |
Why?
|
Cell Survival | 1 | 1988 | 5882 | 0.000 |
Why?
|
Bone Density | 1 | 1990 | 3468 | 0.000 |
Why?
|
Binding, Competitive | 1 | 1978 | 1157 | 0.000 |
Why?
|
Antibodies, Neoplasm | 1 | 1978 | 286 | 0.000 |
Why?
|
Cell Line | 1 | 1990 | 16000 | 0.000 |
Why?
|
Polysaccharides, Bacterial | 1 | 1978 | 578 | 0.000 |
Why?
|
Hydroxyapatites | 1 | 1971 | 75 | 0.000 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1971 | 963 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1978 | 3476 | 0.000 |
Why?
|
Calcium | 1 | 1971 | 5755 | 0.000 |
Why?
|